HEFT Repository

SGLT-2 inhibitors as second-line therapy in type 2 diabetes.

Tahrani, Abd A (2014) SGLT-2 inhibitors as second-line therapy in type 2 diabetes. The lancet. Diabetes & endocrinology, 2 (9). pp. 678-9. ISSN 2213-8595. This article is accessible to all HEFT staff and students via NICE journals and databases http://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases by using their HEFT Athens login IDs

Full text not available from this repository.
Official URL: http://archderm.jamanetwork.com/article.aspx?artic...
Item Type: Article
Additional Information: This article is accessible to all HEFT staff and students via NICE journals and databases http://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases by using their HEFT Athens login IDs
Subjects: WK Endocrine system. Endocrinology
Divisions: Ambulatory Care > Diabetes
Related URLs:
Depositing User: Mrs Yolande Brookes
Date Deposited: 22 Apr 2015 15:23
Last Modified: 22 Apr 2015 15:23
URI: http://www.repository.heartofengland.nhs.uk/id/eprint/860

Actions (login required)

View Item View Item